PCBP2 and malignant glioma: Because the protein levels of ARHGDIA and PCBP2 were negatively correlated, combined ARHGDIA and PCBP2 levels may be considered as potential clinical diagnosis biomarkers or may be predictive of outcomes of malignant glioma patients after surgery.